SFT2D3 anticorps (N-Term)
Aperçu rapide pour SFT2D3 anticorps (N-Term) (ABIN926563)
Antigène
Voir toutes SFT2D3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- SFT2 D3 antibody was raised in rabbit using the N terminal of SFT2 3 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
SFT2D3 Blocking Peptide, (ABIN938209), is also available for use as a blocking control in assays to test for specificity of this SFT2D3 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- SFT2D3 (SFT2 Domain Containing 3 (SFT2D3))
-
Autre désignation
- SFT2D3
-
Sujet
- SFT2D3 may be involved in fusion of retrograde transport vesicles derived from an endocytic compartment with the Golgi complex. Synonyms: Polyclonal SFT2D3 antibody, Anti-SFT2D3 antibody, SFT2 domain containing 3 antibody, MGC5391 antibody.
Antigène
-